CA Stock MarketDetailed Quotes

BIOV BioVaxys Technology Corp

Watchlist
  • 0.070
  • 0.0000.00%
15min DelayMarket Closed May 15 15:35 ET
10.82MMarket Cap-583P/E (TTM)

BioVaxys Technology Corp Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Jul 31, 2023
(Q2)Apr 30, 2023
(Q1)Jan 31, 2023
(FY)Oct 31, 2022
(Q4)Oct 31, 2022
(Q3)Jul 31, 2022
(Q2)Apr 30, 2022
(Q1)Jan 31, 2022
(FY)Oct 31, 2021
(Q4)Oct 31, 2021
Assets
Current assets
Cash, cash equivalents and short term investments
-98.92%423
-74.92%28.48K
-51.94%71.61K
-76.08%141.9K
-76.08%141.9K
-94.73%39.05K
-91.77%113.57K
-82.62%148.99K
-75.52%593.12K
-75.52%593.12K
-Cash and cash equivalents
-98.92%423
-74.92%28.48K
-51.94%71.61K
-76.08%141.9K
-76.08%141.9K
-94.73%39.05K
-91.77%113.57K
-82.62%148.99K
-75.52%593.12K
-75.52%593.12K
Total current assets
250.48%940.37K
199.10%1.17M
170.39%1.11M
-18.29%714.53K
-18.29%714.53K
-88.17%268.31K
-74.81%390.51K
-67.96%410.37K
-71.44%874.49K
-71.44%874.49K
Non current assets
-Goodwill
-95.87%305.35K
-82.21%1.32M
----
--0
--0
0.00%7.4M
0.00%7.4M
0.00%7.4M
0.00%7.4M
0.00%7.4M
-Other intangible assets
--180.63K
--180.63K
----
----
----
----
----
----
----
----
Regulatory assets
131.54%260.13K
106.63%256.37K
102.26%245.42K
59.51%212K
59.51%212K
124.09%112.35K
678.86%124.07K
488.22%121.34K
175.08%132.91K
175.08%132.91K
Total assets
112.77%79.44K
62.88%72.33K
114.08%81.33K
-7.50%45.29K
-7.50%45.29K
-25.53%37.34K
178.76%44.41K
84.16%37.99K
1.33%48.96K
1.33%48.96K
Liabilities
Current liabilities
-accounts payable
8.85%1.48M
59.45%1.32M
99.40%1.42M
506.44%1.31M
506.44%1.31M
533.25%1.36M
288.87%828.5K
304.88%714.27K
-71.28%216.47K
-71.28%216.47K
-Total tax payable
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
-Due to related parties current
96.86%485.67K
225.76%362.2K
235.19%345.63K
184.25%205.46K
184.25%205.46K
503.69%246.71K
2.97%111.18K
6.10%103.12K
-24.53%72.28K
-24.53%72.28K
Current accrued expenses
-16.09%67.41K
6.14%72.09K
108.65%106K
217.20%120.9K
217.20%120.9K
122.33%80.34K
96.72%67.92K
12.15%50.8K
-24.54%38.12K
-24.54%38.12K
Current liabilities
20.51%2.04M
74.21%1.76M
116.07%1.88M
401.46%1.64M
401.46%1.64M
478.31%1.69M
183.39%1.01M
172.24%868.19K
-63.69%326.86K
-63.69%326.86K
Non current liabilities
Long term debt and capital lease obligation
140.89%180.69K
131.01%184.04K
96.87%164.09K
98.59%166.71K
98.59%166.71K
--75.01K
--79.67K
--83.35K
--83.95K
--83.95K
Total non current liabilities
20.51%2.04M
74.21%1.76M
116.07%1.88M
401.46%1.64M
401.46%1.64M
478.31%1.69M
183.39%1.01M
172.24%868.19K
-63.69%326.86K
-63.69%326.86K
Shareholders'equity
Share capital
33.53%20.87M
33.79%20.87M
22.22%18.09M
15.55%17.05M
15.55%17.05M
10.64%15.63M
28.63%15.6M
35.67%14.8M
37.26%14.76M
37.26%14.76M
-common stock
33.53%20.87M
33.79%20.87M
22.22%18.09M
15.55%17.05M
15.55%17.05M
10.64%15.63M
28.63%15.6M
35.67%14.8M
37.26%14.76M
37.26%14.76M
Gains losses not affecting retained earnings
19.97%1.96M
22.70%1.9M
16.04%1.86M
23.68%1.78M
23.68%1.78M
32.01%1.63M
45.82%1.55M
189.92%1.61M
287.77%1.44M
287.77%1.44M
Total equity
-82.09%1.41M
-66.86%2.65M
-84.33%1.26M
-89.82%865.56K
-89.82%865.56K
-18.40%7.89M
-10.52%8.01M
-7.38%8.04M
-18.70%8.5M
-18.70%8.5M
(Q3)Jul 31, 2023(Q2)Apr 30, 2023(Q1)Jan 31, 2023(FY)Oct 31, 2022(Q4)Oct 31, 2022(Q3)Jul 31, 2022(Q2)Apr 30, 2022(Q1)Jan 31, 2022(FY)Oct 31, 2021(Q4)Oct 31, 2021
Assets
Current assets
Cash, cash equivalents and short term investments -98.92%423-74.92%28.48K-51.94%71.61K-76.08%141.9K-76.08%141.9K-94.73%39.05K-91.77%113.57K-82.62%148.99K-75.52%593.12K-75.52%593.12K
-Cash and cash equivalents -98.92%423-74.92%28.48K-51.94%71.61K-76.08%141.9K-76.08%141.9K-94.73%39.05K-91.77%113.57K-82.62%148.99K-75.52%593.12K-75.52%593.12K
Total current assets 250.48%940.37K199.10%1.17M170.39%1.11M-18.29%714.53K-18.29%714.53K-88.17%268.31K-74.81%390.51K-67.96%410.37K-71.44%874.49K-71.44%874.49K
Non current assets
-Goodwill -95.87%305.35K-82.21%1.32M------0--00.00%7.4M0.00%7.4M0.00%7.4M0.00%7.4M0.00%7.4M
-Other intangible assets --180.63K--180.63K--------------------------------
Regulatory assets 131.54%260.13K106.63%256.37K102.26%245.42K59.51%212K59.51%212K124.09%112.35K678.86%124.07K488.22%121.34K175.08%132.91K175.08%132.91K
Total assets 112.77%79.44K62.88%72.33K114.08%81.33K-7.50%45.29K-7.50%45.29K-25.53%37.34K178.76%44.41K84.16%37.99K1.33%48.96K1.33%48.96K
Liabilities
Current liabilities
-accounts payable 8.85%1.48M59.45%1.32M99.40%1.42M506.44%1.31M506.44%1.31M533.25%1.36M288.87%828.5K304.88%714.27K-71.28%216.47K-71.28%216.47K
-Total tax payable --0--0--0--0--0--0--0--0--0--0
-Due to related parties current 96.86%485.67K225.76%362.2K235.19%345.63K184.25%205.46K184.25%205.46K503.69%246.71K2.97%111.18K6.10%103.12K-24.53%72.28K-24.53%72.28K
Current accrued expenses -16.09%67.41K6.14%72.09K108.65%106K217.20%120.9K217.20%120.9K122.33%80.34K96.72%67.92K12.15%50.8K-24.54%38.12K-24.54%38.12K
Current liabilities 20.51%2.04M74.21%1.76M116.07%1.88M401.46%1.64M401.46%1.64M478.31%1.69M183.39%1.01M172.24%868.19K-63.69%326.86K-63.69%326.86K
Non current liabilities
Long term debt and capital lease obligation 140.89%180.69K131.01%184.04K96.87%164.09K98.59%166.71K98.59%166.71K--75.01K--79.67K--83.35K--83.95K--83.95K
Total non current liabilities 20.51%2.04M74.21%1.76M116.07%1.88M401.46%1.64M401.46%1.64M478.31%1.69M183.39%1.01M172.24%868.19K-63.69%326.86K-63.69%326.86K
Shareholders'equity
Share capital 33.53%20.87M33.79%20.87M22.22%18.09M15.55%17.05M15.55%17.05M10.64%15.63M28.63%15.6M35.67%14.8M37.26%14.76M37.26%14.76M
-common stock 33.53%20.87M33.79%20.87M22.22%18.09M15.55%17.05M15.55%17.05M10.64%15.63M28.63%15.6M35.67%14.8M37.26%14.76M37.26%14.76M
Gains losses not affecting retained earnings 19.97%1.96M22.70%1.9M16.04%1.86M23.68%1.78M23.68%1.78M32.01%1.63M45.82%1.55M189.92%1.61M287.77%1.44M287.77%1.44M
Total equity -82.09%1.41M-66.86%2.65M-84.33%1.26M-89.82%865.56K-89.82%865.56K-18.40%7.89M-10.52%8.01M-7.38%8.04M-18.70%8.5M-18.70%8.5M

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
%Chg